Spotlight
Video

Annual Meeting Highlights, Pt 10: After Resistance to Crizotinib in ALK-Positive Advanced NSCLC

cancergrace has 795 videos Subscribe Here

Loading........
Description: http://cancerGRACE.org/...

Dr. Edward Garon, David Geffen School of Medicine at UCLA, describes the exciting developments with LDK-378 and potentially other second generation ALK inhibitors for crizotinib-resistant ALK-positive advanced NSCLC.

GRACEcast 169 Lung
Shared By : cancergrace
Posted on : 09/03/13
Added : 4 years ago
Category : Other